These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7317744)

  • 1. The early changes in the development of bladder cancer in patients exposed to known industrial carcinogens.
    Glashan RW; Wijesinghe DP; Riley A
    Br J Urol; 1981 Dec; 53(6):571-7. PubMed ID: 7317744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytologic detection of urothelial cancer and other abnormalities in a cohort of workers exposed to aromatic amines.
    Crosby JH; Allsbrook WC; Koss LG; Bales CE; Witherington R; Schulte PA; Hemstreet G; Ringer K
    Acta Cytol; 1991; 35(3):263-8. PubMed ID: 2042428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
    Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
    J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumours of the urinary bladder.
    Wood M; Bonser GM
    IARC Sci Publ (1971); 1979; 23():301-4. PubMed ID: 398834
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of bladder washings and urine cytology in the diagnosis of bladder cancer.
    Trott PA; Edwards L
    J Urol; 1973 Dec; 110(6):664-6. PubMed ID: 4757548
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in local surgical treatment of invasive bladder cancer, with special reference to the presence of urothelial dysplasia.
    Wolf H; Højgaard K
    Cancer; 1983 May; 51(9):1710-5. PubMed ID: 6831368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities for the use of exfoliative urine cytology in invasive and noninvasive bladder cancer].
    Stadie G; Ebert W; Müller H
    Z Urol Nephrol; 1985 Jun; 78(6):331-7. PubMed ID: 4036385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study of bladder cancer with cytology and biopsy.
    Loening S; Narayana A; Yoder L; Slymen D; Weinstein S; Penick G; Culp D
    Br J Urol; 1978 Dec; 50(7):496-501. PubMed ID: 572723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening workers exposed to suspect bladder carcinogens.
    Cartwright RA
    J Occup Med; 1986 Oct; 28(10):1017-9. PubMed ID: 3772536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of exfoliative cytology of the urinary bladder in occult bladder cancer and in the control of treated cancers].
    Schmitz A; Meyer U; Kierfeld G; Küchemann K
    Urologe A; 1984 Sep; 23(5):278-80. PubMed ID: 6542269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine cytology: early diagnosis of induced carcinoma of the rat urinary bladder.
    Reznik G; Brennan LM; Creasia DA
    Anticancer Res; 1981; 1(6):389-92. PubMed ID: 7344612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
    Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V
    Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What is the value of urine cytology in after-care of patients with urothelial cancers?].
    Möllhoff S; Rathert P
    Urologe A; 1992 Jul; 31(4):203-5. PubMed ID: 1514198
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and treatment of urothelial premalignant and malignant lesions.
    Wijkström H; Cohen SM; Gardiner RA; Kakizoe T; Schoenberg M; Steineck G; Tobisu K
    Scand J Urol Nephrol Suppl; 2000; (205):116-35. PubMed ID: 11144892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancerous and precancerous changes in the tumor margin areas of patients with bladder cancers].
    Blume B; Theuring F
    Z Urol Nephrol; 1985 Feb; 78(2):71-6. PubMed ID: 3993243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histologic and cytologic aspects of urothelial atypia (dysplasia)].
    Helpap B; Bödeker J; Pfitzenmaier N
    Pathologe; 1985 Nov; 6(6):292-7. PubMed ID: 4088975
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atypical urothelial cells (AUC): A Bethesda-derived wording applicable to urinary cytopathology].
    Piaton E; Advenier AS; Benaïm G; Petrucci MD; Lechevallier FM; Ruffion A
    Ann Pathol; 2011 Feb; 31(1):11-7. PubMed ID: 21349383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant cells in the urine of men exposed to beta-naphthylamine.
    Connolly JG; White EP
    Can Med Assoc J; 1969 May; 100(19):879-82. PubMed ID: 5789538
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dysplasias and carcinomas in situ of the urothelium].
    Mihatsch MJ
    Helv Chir Acta; 1985 Sep; 52(3-4):435-46. PubMed ID: 4066371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.